
A US$5.5 billion deal that would have merged two North Texas financial institutions into a “super-regional bank” is being called off.
Dallas-based Texas Capital Bancshares and McKinney-based Independent Bank Group Inc. described the termination Tuesday as a mutual agreement “given the significant impact of the COVID-19 pandemic on global markets and on the companies’ ability to fully realize the benefits they expected to achieve through the merger.”
The two banks had agreed to an all-stock merger in December. It would have created the largest Texas-based bank in deposits based in the state at US$39 billion, the companies stated at the time, citing S&P Global and Federal Deposit Insurance Corp. data.
Texas Capital also announced Tuesday, May 26, that its longtime CEO, C. Keith Cargill, is stepping down as president and chief executive, effective immediately. Larry L. Helm, the bank’s board chairman since 2012, will become executive chairman, CEO, and president until a permanent successor is found. It hired executive search firm Egon Zehnder to assist in the recruiting process.
“As part of our focus on succession planning, the board believes that it is the right time for a transition in leadership as the company executes a strategy to achieve enhanced operational focus and profitable, long-term value creation,” said a statement from Elysia Ragusa, chair of Texas Capital’s governance and nominating committee.
Full Content: The Dallas Morning News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas